Results 221 to 230 of about 71,955 (233)
Some of the next articles are maybe not open access.

Microwave ablation for the treatment of arterial epistaxis: “how I do it”

International Forum of Allergy and Rhinology, 2019
Arterial epistaxis is commonly seen in the rhinology clinic and can have a significant impact on quality of life. Previous studies have explored various therapies to address epistaxis.
Z. Lou, Yihan Dong, Z. Lou
semanticscholar   +1 more source

Sclerotherapy and Topical Nasal Propranolol: An Effective and Safe Therapy for HHT‐Epistaxis

The Laryngoscope, 2019
Epistaxis is the most frequent clinical manifestation of hereditary hemorrhagic telangiectasia (HHT). Several topical, systemic, and surgical treatments have been tried, but none have been completely effective. The aim of the present study is to evaluate
S. Esteban-Casado   +7 more
semanticscholar   +1 more source

Topical Tranexamic Acid for the Treatment of Acute Epistaxis: A Systematic Review and Meta-analysis

The Annals of Pharmacotherapy, 2018
Objective: To compare topical tranexamic acid (TXA) with control groups for the treatment of acute epistaxis assessing bleeding cessation, discharge within 2 hours, rebleeding rates, complication rates, and patient satisfaction.
M. Gottlieb, Joshua M. DeMott, G. Peksa
semanticscholar   +1 more source

Evaluation of Knowledge, Attitude and Practice of Epistaxis among the General Population of Tabuk City, Saudi Arabia

The Egyptian Journal of Hospital Medicine, 2019
Background: epistaxis is a fairly common problem, which has been reported to be occurring in about 60% of the population. It defined as a bleeding from nose or nasal cavity and it is considered as one of the most common emergencies presenting in Ear ...
Mohammed A. Alhejaily   +3 more
semanticscholar   +1 more source

The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review.

Journal of Laryngology and Otology, 2018
BACKGROUND Hereditary haemorrhagic telangiectasia is an autosomal dominant condition, characterised by mucocutaneous telangiectasia, aneurysm and arteriovenous malformations. Thalidomide has been used as a therapeutic strategy for refractory epistaxis in
L. Harrison, A. Kundra, P. Jervis
semanticscholar   +1 more source

Identification of bleeding sites and microwave thermal ablation of posterior epistaxis

Acta Oto-Laryngologica, 2019
Background: Microwave ablation (MWA) is a relatively new technique which has been used to achieve hemostasis at surgical field. However, few publications have reported MWA for epistaxis.
Z. Lou, Hong-fan Wei, Z. Lou
semanticscholar   +1 more source

Intranasal Efudix reduces epistaxis in hereditary hemorrhagic telangiectasia

Angiogenesis, 2020
D. D. Jel   +4 more
semanticscholar   +1 more source

Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia–Related Epistaxis and Gastrointestinal Bleeding

Mayo Clinic proceedings, 2018
V. Iyer   +15 more
semanticscholar   +1 more source

Severe spontaneous epistaxis: retrospective study in a tertiary ENT centre

European Archives of Oto-Rhino-Laryngology, 2019
Eline Marin   +3 more
semanticscholar   +1 more source

Epistaxis.

Emergency medicine clinics of North America, 2019
Neil Krulewitz, M. Fix
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy